Peer-reviewedLicence not statedHaematologica
Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
Related
- Individual-level expression deconvolution and assessment of cross-sample variation
- The role and evolution of partial splenic embolization over three decades: A multicentric retrospective single cohort study of 90 patients from French nationwide experience
- Concurrent Loss of PIGA and ZRSR2 in a Patient With Paroxysmal Nocturnal Hemoglobinuria and Myelodysplastic Neoplasm
- Diagnostic and Clinical Considerations in Myeloid Neoplasms with del(5q): Distinguishing Myelodysplastic Neoplasm with Low Blasts and del(5q) from Myeloid Neoplasms with del(5q) Post-Cytotoxic Therapy
- The fraction of CD117/c-KIT-expressing erythroid precursors predicts ESA response in low-risk myelodysplastic syndromes.
BibTeX
@article{bardet2026multicentric,
title = {{Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.}},
author = {Valérie Bardet and Wagner-Ballon O and Guy J and Morvan C and Debord C and Trimoreau F and Benayoun E and Chapuis N and Freynet N and Rossi C and Mathis S and Gourin Mp and Toma A and Béné Mc and Groupe D ’etude Immunologique Des Geil},
journal = {Haematologica},
year = {2026},
month = oct,
doi = {10.3324/haematol.2014.112755},
url = {https://hal.science/hal-05785561v1},
}
RIS
TY - JOUR
TI - Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
AU - Valérie Bardet
AU - Wagner-Ballon O
AU - Guy J
AU - Morvan C
AU - Debord C
AU - Trimoreau F
AU - Benayoun E
AU - Chapuis N
AU - Freynet N
AU - Rossi C
AU - Mathis S
AU - Gourin Mp
AU - Toma A
AU - Béné Mc
AU - Groupe D ’etude Immunologique Des Geil
PY - 2026
DA - 2026/10/08
JO - Haematologica
DO - 10.3324/haematol.2014.112755
UR - https://hal.science/hal-05785561v1
SN - 0390-6078
SN - 1592-8721
ER -